Next Article in Journal
The Multifaceted Roles of STAT3 Signaling in the Progression of Prostate Cancer
Previous Article in Journal
Neutrophil Gelatinase-Associated Lipocalin (NGAL), Pro-Matrix Metalloproteinase-9 (pro-MMP-9) and Their Complex Pro-MMP-9/NGAL in Leukaemias
Previous Article in Special Issue
Leptin’s Pro-Angiogenic Signature in Breast Cancer
Article Menu

Export Article

Open AccessReview
Cancers 2014, 6(2), 813-828; doi:10.3390/cancers6020813

Critical Role of Aberrant Angiogenesis in the Development of Tumor Hypoxia and Associated Radioresistance

1
Department of Radiotherapy and Radiation Oncology, Klinikum rechts der Isar, Technische Universität München, Ismaninger Straße 22, 81675 Munich, Germany
2
Clinical Cooperation Group "Innate Immunity in Tumor Biology", Helmholtz Zentrum München (HMGU), Ingolstädter Landstraße 1, 85764 Neuherberg, Germany
3
GmbH, Munich, Ismaningerstr. 22, 81675 Munich, Germany
*
Author to whom correspondence should be addressed.
Received: 7 February 2014 / Revised: 18 March 2014 / Accepted: 21 March 2014 / Published: 8 April 2014
(This article belongs to the Special Issue Tumour Angiogenesis)
View Full-Text   |   Download PDF [502 KB, uploaded 8 April 2014]   |  

Abstract

Newly formed microvessels in most solid tumors show an abnormal morphology and thus do not fulfil the metabolic demands of the growing tumor mass. Due to the chaotic and heterogeneous tumor microcirculation, a hostile tumor microenvironment develops, that is characterized inter alia by local hypoxia, which in turn can stimulate the HIF-system. The latter can lead to tumor progression and may be involved in hypoxia-mediated radioresistance of tumor cells. Herein, cellular and molecular mechanisms in tumor angiogenesis are discussed that, among others, might impact hypoxia-related radioresistance. View Full-Text
Keywords: tumor angiogenesis; tumor microcirculation; tumor hypoxia; hypoxia-inducible factor (HIF); radioresistance; hypoxia modifiers tumor angiogenesis; tumor microcirculation; tumor hypoxia; hypoxia-inducible factor (HIF); radioresistance; hypoxia modifiers
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Multhoff, G.; Radons, J.; Vaupel, P. Critical Role of Aberrant Angiogenesis in the Development of Tumor Hypoxia and Associated Radioresistance. Cancers 2014, 6, 813-828.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Cancers EISSN 2072-6694 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top